Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: MRR

Global Single Cell Genomics Market Report 2022: Immuno-oncology, Research Range, Technology Maturity & Convergence, & Declining Costs Driving Growth - Forecast to 2027


DUBLIN, Jan. 19, 2022 /PRNewswire/ -- The "Global Single Cell Genomics Market Forecasts by End-user & Technology with Executive & Consultant Guides, Including Customized Forecasting and Analysis with COVID-19 Updates" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

Single Cell Genomics is emerging as a mainstay of scientific research and development. New life forms have already been identified. This means new diseases and new cures.

The technology is moving faster than the market. Genomics and Immunology are playing a role too. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.

There are applications in every aspect of healthcare. Just coming out of the lab it is finding its footing in new clinical applications especially related to immune-oncology and microbiology. But the largest market is still in research and the market is booming as understanding the genomics of individual cells opens up a whole new world of biotechnology.

This is a complex area but this readable report will bring the entire management team up to speed, on both the technology and the opportunity.

Single Cell Genomics Recent Developments

Market Trends

Factors Driving Growth

Factors Limiting Growth

Technology Development

Industry Overview

Profiles of Key Single Cell Genomics Companies

For more information about this report visit https://www.researchandmarkets.com/r/aaj016

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 21:00
SETC-Assistance.org Helps Eligible Self-Employed Workers Receive Up to $32,220 in Tax Credits Through SETC Program
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages QuidelOrtho Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - QDEL
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
U.S. FDA Approves Subcutaneous Administration of Takeda's ENTYVIO® (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn's Disease
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Bladex announces 1Q24 Net Profit of $51.3 Million, or $1.40 per share, expanding its annualized return on equity to 16.8% in 1Q24
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...

at 17:20
NOVAGOLD Releases 2023 Sustainability Report
Providing a comprehensive overview of NOVAGOLD's Environmental, Social and Governance (ESG) performance, emphasizing remarkable health and safety records, steadfast dedication to environmental protection, continuous community investment, extensive...

at 16:45
Dogness Reports Financial Results for the Six Months Ended December 31, 2023
Dogness (International) Corporation ("Dogness" or the "Company") , a developer and manufacturer of a comprehensive line of Dogness-branded, OEM and private label pet products, today announced its financial results for the six months ended December...

More news about Covid-19 virus...


News published on and distributed by: